BioSpace News Archive

Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology.

An inventor from Oxford, Pa., has developed the WALKER/SCOOTER LIGHT, an accessory for mobility devices featuring enhanced safety and functionality.

Houlihan Lokey (NYSE: HLI), the global investment bank, today announced that Dimitri Drone has joined the firm as a Managing Director in Financial Advisory Services as part of a continued build-out of the firm’s pharmaceutical & life sciences valuation services.

Preliminary antitumor activity observed in ROS1 fusion-positive NSCLC patients across multiple doses of TPX-0005 with additional responders pending confirmation Ten Confirmed RECIST Partial Responses (1 NTRK; 7 ROS1 TKI naïve; 2 ROS1 TKI pretreated) with longest duration of treatment of 13.4+ months and 70% of responses ongoing

As a result she developed the CareBit, CareBit Plus to monitor the care and track the activity of a loved one in a hospital, rehabilitation facility or nursing home.

Genome Canada launched a national initiative for the clinical implementation of precision health, focusing on a rare disease pilot program as a foundational step.

Micronics, Inc. has announced today that its test for the detection of Shiga toxin-producing E. coli (STEC) has received clearance from the U.S. Food and Drug Administration.

Bruker announced that it has acquired Sierra Sensors GmbH, based in Hamburg, Germany.

Virpax Pharmaceuticals (“Virpax”), signed a technology license agreement with LipoCure to develop pain management products.

Qosina is pleased to add tinted, gamma-sterilizable, large-bore tuohy borst adapters to its existing line of tuohy borsts. Qosina now carries 13 distinct, off-the-shelf options that can accommodate instrument sizes up to 18 FR.